U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090033
Company: LUPIN LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
RIFABUTIN RIFABUTIN 150MG CAPSULE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/24/2014 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/090033Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/12/2024 SUPPL-6 Labeling-Package Insert

Label is not available on this site.

04/12/2024 SUPPL-5 Labeling-Package Insert

Label is not available on this site.

04/12/2024 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

01/10/2016 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

01/10/2016 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

RIFABUTIN

CAPSULE;ORAL; 150MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
MYCOBUTIN RIFABUTIN 150MG CAPSULE;ORAL Prescription Yes AB 050689 PFIZER
RIFABUTIN RIFABUTIN 150MG CAPSULE;ORAL Prescription No AB 090033 LUPIN LTD
RIFABUTIN RIFABUTIN 150MG CAPSULE;ORAL Prescription No AB 215041 NOVITIUM PHARMA
Back to Top